Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | GFER | P55789 | 1/20 | 0.65 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | THRB | P10828 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | APEX1 | P27695 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30120212 | 1.00 | KMT2A (0.65) | KMT2AKDM4EGFERRXFP1MAPT | |
| Hydrochloric Acid SCHEMBL27577526 | 0.98 | KMT2A (0.67) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL8220007 | 0.89 | KDM4E (0.55) | KMT2AKDM4EGFERRXFP1MAPT | |
| Alcohol SCHEMBL28066280 | 0.89 | KMT2A (0.56) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL562543 | 0.82 | IKBKB (0.55) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL20853600 | 0.82 | CA12 (0.45) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL440293 | 0.82 | ALDH1A1 (0.61) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL11840032 | 0.80 | ALDH1A1 (0.46) | KMT2AKDM4EGFERRXFP1MAPT | |
| Hydrochloric Acid SCHEMBL9797011 | 0.80 | ALDH1A1 (0.59) | KMT2AKDM4EGFERRXFP1MAPT | |
| SCHEMBL9851201 | 0.79 | MAPT (0.66) | KMT2AMAPTMEN1USP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120195409-A | Composition for diagnosing sepsis and medicament for sepsis preventive treatment | 北京大学第三医院（北京大学第三临床医学院） | 2025-06-24 | — | — | CN | claimed |
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION (KR) | 2025-05-15 | — | — | US | claimed |
| CN-119529929-A | Lubricating oil composition for improving friction characteristics of gears and preparation method thereof | 中国石油天然气股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119529210-A | Ashless dispersant, and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118566488-A | Reagent combination for detecting depression, manufacturing method, detection system and application thereof | 合肥歆智医疗器械有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-116377715-B | High-elasticity ultraviolet-resistant fabric and preparation method thereof | 盐城市金达纺织有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118294676-A | Depression detection reagent based on key marker, detection system and application thereof | 合肥歆智医疗器械有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118230955-A | Model training method for depression detection, detection system, program, and storage medium | 合肥歆智医疗器械有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118226045-A | Detection method, reagent and detection system for simultaneously detecting more than ten markers | 合肥歆智医疗器械有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118126051-A | Polymorphic substance of mutant BRAF degradation agent and preparation method thereof | C4医药公司 | 2024-06-04 | — | — | CN | claimed |
| EP-0648488-B1 | Method to alter hairgrowth and compositions therefor | OREAL (FR) | 2000-11-29 | — | — | EP | claimed |
| WO-2000059875-A2 | NOVEL INHIBITORS OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE'S) | CITY OF HOPE (US) | 2000-10-12 | — | — | WO | claimed |
| US-5928654-A | Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors | SOCIETE L'OREAL S.A. (FR) | 1999-07-27 | — | — | US | claimed |
| US-5919846-A | COLORFASTNESS; WATERPROOFING | MILLIKEN RESEARCH CORPORATION (US) | 1999-07-06 | — | — | US | claimed |
| EP-0474874-B1 | Maillard Reaction inhibitor compositions | SENJU PHARMA CO (JP) | 1995-10-18 | — | — | EP | claimed |
| EP-0455168-B1 | DYEING COMPOSITION FOR KERATIN FIBER | Kao Corporation (JP) | 1993-09-22 | — | — | EP | claimed |
| EP-0474874-A1 | Maillard Reaction inhibitor compositions | Senju Pharmaceutical Co., Ltd. (JP) | 1992-03-18 | — | — | EP | claimed |
| US-5089026-A | 1,5-Dihydroxynaphthalene, 2-amino-5-hydroxybenzoic acid, cosmetically acceptable base | KAO CORPORATION (JP) | 1992-02-18 | — | — | US | claimed |
| EP-0455168-A1 | Dyeing composition for keratin fiber | Kao Corporation (JP) | 1991-11-06 | — | — | EP | claimed |
| US-4314078-A | Process for preparing 5-(2-chloro-4-trifluoromethylphenoxy)-2-nitro-N-alkanesulphonyl benzamides from a benzoic acid derivative and intermediates | ICI AMERICAS INC. (US) | 1982-02-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | OAT, MCCC2, OTC | KMT2A 399/4885KDM4E 1289/4885GFER 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.